Literature DB >> 26762127

Assessing the effect of preoperative levosimendan on renal function in patients with right ventricular dysfunction.

Jose L Guerrero Orriach1, M Galán Ortega2, A Ramírez Fernandez2, D Ariza Villanueva2, A Florez Vela2, I Moreno Cortés2, M Rubio Navarro2, J Cruz Mañas2.   

Abstract

The Acute Kidney Injury Network (AKIN) classification considers SCr values, urea and urine output in order to improve timely diagnose ARF and improve patient prognosis by early treatment. Preoperative levosimendan is a new way for cardiac and kidney protection, we try to evaluate this drug in fifteen patients comparing values of AKIN scale parameters pre and post cardiac surgery in patients with right ventricle dysfunction.

Entities:  

Keywords:  AKIN scale; Acute renal failure; Kidney; Levosimendan; Preoperative

Mesh：

Substances：

Year:  2016        PMID： 26762127     DOI： 10.1007/s10877-016-9827-7

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN： 1387-1307            Impact factor:   2.502


  15 in total

Review 1.  [Evidence-based management of right heart failure: a systematic review of an empiric field].

Authors:  Mehdi Skhiri; Sharon A Hunt; André Y Denault; François Haddad
Journal:  Rev Esp Cardiol       Date:  2010-04       Impact factor: 4.753

2.  Superior vena cava flow and tricuspid anular motion after cardioversion of atrial fibrillation, and role of right atrial relaxation on systolic venous return.

Authors:  H Ochi; S Izumi; R Murakami; T Shimada; S Morioka; K Moriyama
Journal:  Am J Cardiol       Date:  1991-11-15       Impact factor: 2.778

Review 3.  Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference.

Authors:  G Landoni; J G Augoustides; F Guarracino; F Santini; M Ponschab; D Pasero; R N Rodseth; G Biondi-Zoccai; G Silvay; L Salvi; E Camporesi; M Comis; M Conte; S Bevilacqua; L Cabrini; C Cariello; F Caramelli; V De Santis; P Del Sarto; D Dini; A Forti; N Galdieri; G Giordano; L Gottin; M Greco; E Maglioni; L Mantovani; A Manzato; M Meli; G Paternoster; D Pittarello; K N Rana; L Ruggeri; V Salandin; F Sangalli; M Zambon; M Zucchetti; E Bignami; O Alfieri; A Zangrillo
Journal:  Acta Anaesthesiol Scand       Date:  2011-03       Impact factor: 2.105

4.  Preoperative levosimendan for right ventricular dysfunction before heart valve replacement surgery.

Authors:  José Luis Guerrero Orriach; Isabel Navarro Arce; Pablo Iglesias; Manuel Galán Ortega; Manuel Rubio Navarro; José Cruz Mañas
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2013-08-30

5.  Levosimendan improves renal outcome in cardiac surgery: a randomized trial.

Authors:  Ayse Baysal; Mehmet Yanartas; Mevlut Dogukan; Narin Gundogus; Tuncer Kocak; Cengiz Koksal
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-01-18       Impact factor: 2.628

6.  Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure.

Authors:  François Haddad; Eric Fuh; Tyler Peterson; Mehdi Skhiri; Kristina T Kudelko; Vinicio De Jesus Perez; Wolfgang C Winkelmayer; Ramona L Doyle; Glenn M Chertow; Roham T Zamanian
Journal:  J Card Fail       Date:  2011-04-22       Impact factor: 5.712

7.  Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy.

Authors:  Carlo Lucioni; Alessandra D'Ambrosi; Silvio Mazzi; Piero Pollesello; Marjo Apajasalo; Francesco Fedele
Journal:  Adv Ther       Date:  2012-12-06       Impact factor: 3.845

8.  Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass.

Authors:  Ricardo Levin; Marcela Degrange; Carlos Del Mazo; Eduardo Tanus; Rafael Porcile
Journal:  Exp Clin Cardiol       Date:  2012-09

9.  Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms.

Authors:  Francesco Fedele; Noemi Bruno; Bruno Brasolin; Carmen Caira; Alessandra D'Ambrosi; Massimo Mancone
Journal:  Eur J Heart Fail       Date:  2013-12-11       Impact factor: 15.534

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more
  3 in total

1.  Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01.

Authors:  Jose L Guerrero-Orriach; Alfredo Malo-Manso; Marta Ramirez-Aliaga; Ana Isabel Florez Vela; Manuel Galán-Ortega; Isabel Moreno-Cortes; Inmaculada Gonzalez-Almendros; Alicia Ramirez-Fernandez; Daniel Ariza-Villanueva; Juan Jose Escalona-Belmonte; Guillermo Quesada-Muñoz; Enrique Sepúlveda-Haro; Salvador Romero-Molina; Inmaculada Bellido-Estevez; Aurelio Gomez-Luque; Manuel Rubio-Navarro; Juan Alcaide-Torres; Concepcion Santiago-Fernandez; Lourdes Garrido-Sanchez; Jose Cruz-Mañas
Journal:  Front Pharmacol       Date:  2020-08-26       Impact factor: 5.810

Review 2.  Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.

Authors:  Filippo Sanfilippo; Joshua B Knight; Sabino Scolletta; Cristina Santonocito; Federico Pastore; Ferdinando L Lorini; Luigi Tritapepe; Andrea Morelli; Antonio Arcadipane
Journal:  Crit Care       Date:  2017-10-19       Impact factor: 9.097

3.  Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase.

Authors:  José Luis Guerrero-Orriach; Daniel Ariza-Villanueva; Ana Florez-Vela; Lourdes Garrido-Sánchez; María Isabel Moreno-Cortés; Manuel Galán-Ortega; Alicia Ramírez-Fernández; Juan Alcaide Torres; Concepción Santiago Fernandez; Isabel Navarro Arce; José María Melero-Tejedor; Manuel Rubio-Navarro; José Cruz-Mañas
Journal:  Ther Clin Risk Manag       Date:  2016-04-21       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.